A polymorphism in the human agouti-related protein is associated with late-onset obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4198-4202

  Argyropoulos, George ^a,b,c,d,e   Rankinen, Tuomo ^a,b,c,d,e   Neufeld, Doni R ^a,b,c,d,e   Rice, Treva ^a,b,c,d,e   Province, Michael A ^a,b,c,d,e   Leon, Arthur S ^a,b,c,d,e   Skinner, James S ^a,b,c,d,e   Wilmore, Jack H ^a,b,c,d,e   Rao, D C ^a,b,c,d,e   Bouchard, Claude ^a,b,c,d,e  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d INDIANA UNIVERSITY   (United States)

^e TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; ALANINE; HUMAN AGOUTI RELATED PROTEIN; ISOPROTEIN; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGE; AMINO ACID SUBSTITUTION; APPETITE; ARTICLE; CHROMOSOME 16Q; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERPHAGIA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; OBESITY; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SUGAR INTAKE; TRANSGENIC MOUSE;

ADENINE; ADULT; AGE OF ONSET; ANIMALS; EXONS; FEMALE; GENOTYPE; GUANINE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

AGOUTI; ANIMALIA; MUS MUSCULUS;

EID: 18544363922     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-011834     Document Type: Article

References (44)

1. Williams G, Harrold JA, Cutler DJ 2000 The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc 59:385-396
2. Beck B 2000 Neuropeptides and obesity. Nutrition 16:916-923
3. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138
4. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL 1997 Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11:593-602
5. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
6. Rosenfeld RD, Zeni L, Welcher AA, Narhi LO, Hale C, Marasco J, Delaney J, Gleason T, Philo JS, Katta V, Hui J, Baumgartner J, Graham M, Stark KL, Karbon W 1998 Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry 37:16041-16052
7. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, Seeley RJ 2000 Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol 279:R47-R52
8. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL 1997 Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 17:273-274
9. Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA, Bloom SR 2001 Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50:248-254
10. Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW 2000 Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 49:244-252
11. Schwartz MW, Baskin DG, Bukowski TR, et al. 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531-535
12. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T 1998 The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048
13. Wilson BD, Ollmann MM, Barsh GS 1999 The role of agouti-related protein in regulating body weight. Mol Med Today 5:250-256
14. Ebihara K, Ogawa Y, Katsuura G, et al. 1999 Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033
15. Fong TM, Mao C, MacNeil T, et al. 1997 ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 237:629-631
16. 2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett 428:59-62
17. Brown AM, Mayfield DK, Volaufova J, Argyropoulos G 2001 The gene structure and minimal promoter of the human agouti related protein. Gene 277:231-238
18. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC 1996 Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93:6231-6235
19. Darnell Jr JE 1996 Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc Natl Acad Sci USA 93:6221-6224
20. Mizuno TM, Mobbs CV 1999 Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140:814-817
21. Wilson BD, Bagnol D, Kaelin CB, et al. 1999 Physiological and anatomical circuitry between agouti-related protein and leptin signaling. Endocrinology 140:2387-2397
22. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD 1999 Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24:155-163
23. Kim MS, Small CJ, Stanley SA, et al. 2000 The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 105:1005-1011
24. Kim MS, Rossi M, Abusnana S, et al. 2000 Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone. Diabetes 49:177-182
25. Li JY, Finniss S, Yang YK, et al. 2000 Agouti-related protein-like immunoreactivity: characterization of release from hypothalamic tissue and presence in serum. Endocrinology 141:1942-1950
26. Mihaly E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM 2000 Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and α-melanocyte-stimulating hormone. J Clin Endocrinol Metab 85:2596-2603
27. Mercer JG, Moar KM, Ross AW, Morgan PJ 2000 Regulation of leptin receptor, POMC and AGRP gene expression by photoperiod and food deprivation in the hypothalamic arcuate nucleus of the male Siberian hamster (Phodopus sungorus). Appetite 34:109-111
28. Mayfield DK, Brown AM, Page GP, Garvey WT, Shriver MD, Argyropoulos G 2001 A role for the agouti related protein promoter in obesity and type 2 diabetes. Biochem Biophys Res Commun 287:568-573
29. Vink T, Hinney A, van Elburg AA, et al. 2001 Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol Psychiatry 6:325-38
30. Dubern B, Clement K, Pelloux V, et al. 2001 Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 139:204-209
31. Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, Gagnon J 1995 The HERITAGE family study. Aims, design, and measurement protocol. Med Sci Sports Exerc 27:721-729
32. Wilmore JH, Stanforth PR, Domenick MA, et al. 1997 Reproducibility of anthropometric and body composition measurements: the HERITAGE Family Study. Int J Obes Relat Metab Disord 21:297-303
33. Rankinen T, Gagnon J, Perusse L, et al. 1999 Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism: the heritage family study. Obes Res 7:423-430
34. Wilmore JH, Despres JP, Stanforth PR, et al. 1999 Alterations in body weight and composition consequent to 20 wk of endurance training: the HERITAGE Family Study. Am J Clin Nutr 70:346-352
35. den Dunnen, JT, Antonarakis SE 2000 Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
36. Lupas A, Van Dyke M, Stock J 1991 Predicting coiled coils from protein sequences. Science 252:1162-1164
37. Lupas A 1996 Prediction and analysis of coiled-coil structures. Methods Enzymol 266:513-525
38. Berger B, Wilson DB, Wolf E, Tonchev T, Milla M, Kim PS 1995 Predicting coiled coils by use of pairwise residue correlations. Proc Natl Acad Sci USA 92:8259-8263
39. Katsuki A, Sumida Y, Gabazza EC, et al. 2001 Plasma levels of agouti-related protein are increased in obese men. J Clin Endocrinol Metab 86:1921-1924
40. Morra M, Simarro-Grande M, Martin M, et al. 2001 Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J Biol Chem 276:36809-36816
41. Hellman NE, Kono S, Miyajima H, Gitlin JD 2002 Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 277:1375-1380
42. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ 2001 Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142:1050-1056
43. Wirth MM, Giraudo SQ 2001 Effect of agouti-related protein delivered to the dorsomedial nucleus of the hypothalamus on intake of a preferred versus a non-preferred diet. Brain Res 897:169-174
44. Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ 2001 Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am J Physiol 280:R814-R821